2021-09-13 Comments Off on Results from Phase 0/1 trial of ribociclib plus everolimus in patients with high-grade glioma announced Results from Phase 0/1 trial of ribociclib plus everolimus in patients with high-grade glioma announced The Ivy Brain Tumor Center at Barrow Neurological Institute, the
